Clinical Summary of a U.S. Preventive Services Task Force Recommendation Statement
This document is a summary of the 2008 recommendation of the U.S. Preventive Services Task Force (USPSTF) on universal screening for hearing loss in newborns. This summary is intended for use by primary care clinicians.
Select for copyright and source information.
Population |
All Pregnant Women | Men and Nonpregnant Women |
Recommendation |
Screen with urine culture Grade: A
| Do not screen. Grade: D
|
Detection and Screening Tests |
Asymptomatic bacteriuria can be reliably detected through urine culture.
The presence of at least 105 colony-forming units per mL of urine, of a single uropathogen, and
in a midstream clean-catch specimen is considered a positive test result.
|
Screening Intervals |
A clean-catch urine specimen should be collected for
screening culture at 12–16 weeks' gestation
or at the first prenatal visit, if later.
The optimal frequency of subsequent urine testing during
pregnancy is uncertain.
|
Do not screen.
|
Benefits of Detection and
Early Treatment |
The detection and treatment of asymptomatic bacteriuria
with antibiotics significantly reduces the incidence
of symptomatic maternal urinary tract infections
and low birthweight.
| Screening men and nonpregnant women for asymptomatic
bacteriuria is ineffective in improving clinical outcomes.
|
Harms of Detection and
Early Treatment |
Potential harms associated with treatment of asymptomatic bacteriuria include:
- Adverse effects from antibiotics.
- Development of bacterial resistance.
|
Other Relevant USPSTF Recommendations |
Additional USPSTF recommendations involving screening for infectious conditions during pregnancy can be
found at www.ahrq.gov/clinic/cps3dix.htm#obstetric and www.ahrq.gov/clinic/cps3dix.htm#infectious.
|
For the full recommendation statement and supporting documents (including a summary of the evidence) please go to http://www.preventiveservices.ahrq.gov.
Copyright and Source Information
This document is in the public domain within the United States. For information on reprinting, contact Randie Siegel, Director, Division of Printing and Electronic Publishing, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850.
Requests for linking or to incorporate content in electronic resources should be sent to: info@ahrq.gov.
AHRQ Publication No. 08-05120-EF-2
Current as of July 2008
Internet Citation:
U.S. Preventive Services Task Force. Screening for Asymptomatic Bacteriuria in Adults: Clinical Summary of a U.S. Preventive Services Task Force Recommendation Statement. AHRQ Publication No. 08-05120-EF-2, July 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf08/asymptbact/asbactsum.htm